Skip to main content
    C

    Cocrystal Pharma Inc (COCP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.01
    +0.03 (+3.30%)

    Market Cap: $18.88M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Cocrystal Pharma Inc (COCP) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Cocrystal Pharma (COCP) has a market cap of $18.88M and an enterprise value of $14.01M. It kept -2605.29% of revenue as net income over the last 12 months. Its share count is up 58.48% from a year earlier.

    Total Valuation

    Enterprise value is 25.81% below the market cap, as cash exceeds debt.

    Market Cap$18.88M
    Enterprise Value$14.01M
    Latest price (Nov 17, 2026)$1.01

    Key Dates

    The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 29, 2027 (expected)
    Last Earnings DateNov 13, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 26.33% in the quarter ended Sep 30, 2026 and grew 30.85% a year over 2 years.

    Shares Outstanding17.42M
    Shares Change (YoY)+58.48%
    Shares Change (QoQ)+26.33%
    Share Count Growth (2Y CAGR)+30.85%

    Valuation Ratios

    Sales and book value multiples are 40.4x and 6.6x. Its year-end P/S ranged from 2.4x to 151.1x from 2019 to 2024.

    P/S Ratio40.4x
    Forward P/S0.2x
    P/B Ratio6.6x

    Valuation history and multiples

    Price Statistics

    The stock is down 1.94% over 52 weeks and trades 5.61% below its 50-day average.

    Beta (1Y)1.25
    52-Week Change-1.94%
    1-Month Change+6.70%
    3-Month Change-11.79%
    6-Month Change-12.17%
    5-Year Change-90.71%
    10-Year Change-99.42%
    Total Return (1Y)-1.94%
    Total Return (3Y CAGR)-15.76%
    Total Return (5Y CAGR)-36.81%
    Return vs SPY (1Y)-12.54%
    Max Drawdown (1Y)-47.77%
    Max Drawdown (3Y)-74.77%
    Sharpe Ratio (1Y)-0.01
    Correlation with SPY (1Y)0.25
    50-Day Average$1.07
    200-Day Average$1.10
    52-Week Range$0.76 to $2.03
    RSI (14 Days)48.1
    Average Volume (20 Days)29.29K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.72x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio1.72x
    Quick Ratio1.72x
    Debt / Equity0.00x
    Interest Coverage121.56x

    Returns and Efficiency

    Return on equity is -423.66% and return on assets is -167.33% over the last 12 months.

    Return on Equity (ROE)-423.66%
    Return on Assets (ROA)-167.33%
    ROA (5Y Average)-78.30%
    Asset Turnover0.05x

    Scores

    COCP has an Altman Z-Score of -75.10, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score-75.10
    Altman Z ZoneDistress
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $435.00K over the last 12 months is up 219.85% from the 12 months before.

    Revenue$435.00K
    Revenue Growth (YoY)+219.85%
    Gross Profit$1.83M
    Operating Income-$11.51M
    Pretax Income-$11.33M
    Net Income-$11.33M
    Reported EPS (TTM)-$0.77

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 39.44% of the $6.77M in total assets.

    Cash and Equivalents$4.87M
    Total Debt$0
    Net Cash$4.87M
    Net Cash Per Share$0.28
    Working Capital$2.31M
    Shareholder Equity$2.67M
    Book Value Per Share$0.15
    Total Assets$6.77M
    Total Liabilities$4.10M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$8.89M
    FCF Per Share-$0.46
    Depreciation and Amortization$47.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -2645.98%.

    Gross Margin420.46%
    Operating Margin-2645.98%
    Pretax Margin-2605.29%
    Net Margin-2605.29%

    Growth

    Book Value Per Share Growth (2Y CAGR)-53.50%
    Tangible Book Per Share Growth (2Y CAGR)-53.50%

    Revenue and profit by year

    Dividends and Yields

    COCP does not pay a dividend.

    Buyback Yield-5.87%
    Shareholder Yield-5.87%

    Stock Splits

    The last split was a 1-for-12 reverse split on Oct 11, 2022.

    Last Split DateOct 11, 2022
    Split TypeReverse split
    Split Ratio1:12

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About COCP

    What is COCP's market cap?

    Cocrystal Pharma has a market cap of $18.88M. Its enterprise value, which adds debt and subtracts cash, is $14.01M.

    How many shares of COCP are outstanding?

    Cocrystal Pharma has 17.42M shares outstanding. The count is up 58.48% from a year earlier.

    Does COCP pay a dividend?

    No. Cocrystal Pharma does not pay a dividend.

    How much debt does COCP have?

    Cocrystal Pharma has $0 of total debt and $4.87M of cash and equivalents, a net cash position of $4.87M.